1,3,5-Trimethyl-1H-pyrazol-4-ylboronic acid
Product Information
Molecular Formula
C6H11BN2O2
Molecular Weight
153.97
Description
1,3,5-Trimethyl-1H-pyrazol-4-ylboronic acid, a quintessential biochemical constituent utilized explicitly for the integral construction of the pharmaceuticals. Notably, this entity contributes to research and drug development in cancer, neuro-directed complications, and conditions inherently related to immune health.
Synonyms
1,3,5-Trimethylpyrazole-4-boronic acid; (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronic acid; (1,3,5-trimethylpyrazol-4-yl)boronic Acid; Boronic acid, (1,3,5-trimethyl-1H-pyrazol-4-yl)-; 1,3,5-trimethylpyrazol-4-ylboronic acid; (1,3,5-Trimethyl-1H-pyrazol-4-yl)boronicacid; 1,3,5-Trimethyl-1H-pyrazol-4-ylboronic acid
IUPAC Name
(1,3,5-trimethylpyrazol-4-yl)boronic acid
SMILES
B(C1=C(N(N=C1C)C)C)(O)O
InChI
InChI=1S/C6H11BN2O2/c1-4-6(7(10)11)5(2)9(3)8-4/h10-11H,1-3H3
InChI Key
AWOUMBMZDWJMGM-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
154.0913578 g/mol
Monoisotopic Mass
154.0913578 g/mol
Topological Polar Surface Area
58.3Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
145
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| US-2021346405-A1 | Bcl-2 inhibitors and their use as pharmaceuticals | 2020-04-28 |
| WO-2021222174-A1 | Bcl-2 inhibitors and their use as pharmaceuticals | 2020-04-28 |
| WO-2021072198-A1 | Oral complement factor d inhibitors | 2019-10-09 |
| WO-2019196720-A1 | Arginine methyltransferase inhibitor, pharmaceutical composition thereof and use thereof | 2018-04-08 |
| RU-2760373-C2 | Biaryl derivative and drug containing it | 2015-09-18 |
| US-2017037052-A1 | Furopyridines as inhibitors of protein kinases | 2014-04-30 |
| US-9902733-B2 | Furopyridines as inhibitors of protein kinases | 2014-04-30 |
| WO-2015165428-A1 | Furopyridines as inhibitors of protein kinases | 2014-04-30 |
| EP-3126362-A1 | Anti-fibrotic pyridinones | 2014-04-02 |
| JP-2017512784-A | Antifibrotic pyridinone | 2014-04-02 |
